Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
Clinical trial NCT04902703 · RECRUITING
Trial details
- NCT number
- NCT04902703
- Sponsor
- University of Colorado, Denver
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2026-11-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.